Mustang Bio

Mustang Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products, aiming to harness the power of the patient's own immune system to eliminate cancer cells. Mustang’s goal is to acquire ownership of these technologies through licensing or other means, fund their research and development, and out-license or bring these technologies to market. Mustang collaborates with top medical institutions to advance the development of CAR-T therapies for various cancers and lentiviral gene therapy for XSCID. Mustang was founded by Fortress Biotech, Inc. (NASDAQ: FBIO).